S&P 500 index data: S&P 500 Copyright ©
|Oramed Pharmaceuticals Reports Last Patient Out in Phase IIa Trial for ORMD-0801 in Type 1 Diabetes|
|Oramed to Present at Upcoming Conferences (2014/9/3)|
|Oramed Granted Patent in Spain for Oral Administration of Insulin (2014/8/19)|
|Oramed to Present at Family Office & Wealth Management Conference (2014/9/15)|
Click above to view more mutual fund data and stats for ormp - Oramed Pharmaceuticals Inc.